- Published at
- by themarketherald.com.au
neutral
neutral
First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care
Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing…
News for Imugene Limited (IUGNF)
- Published at
- by themarketherald.com.au
mixedmixedASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024
The ASX 200 is expected to open 0.07% lower at 8,185 points,…- Published at
- by investing.com
positivepositivePrecision BioSciences stock hits 52-week low at $4.12 By Investing.com
Precision BioSciences stock hits 52-week low at $4.12- Published at
- by investing.com
positivepositivePrecision Biosciences CFO buys $10,036 in common stock By Investing.com
Precision Biosciences CFO buys $10,036 in common stock- Published at
- by investing.com
positivepositivePrecision BioSciences stock hits 52-week low at $6.4 By Investing.com
Precision BioSciences stock hits 52-week low at $6.4- Published at
- by investing.com
neutralneutralPrecision BioSciences stock hits 52-week low at $7.94 By Investing.com
Precision BioSciences stock hits 52-week low at $7.94- Published at
- by investing.com
positivepositivePrecision BioSciences begins clinical trial for hepatitis B cure By Investing.com
Precision BioSciences begins clinical trial for hepatitis B cure- Published at
- by investing.com
positivepositivePrecision BioSciences files for gene editing trial By Investing.com
Precision BioSciences files for gene editing trial- Published at
- by vcnewsdaily.com
positivepositivePrecision BioSciences Receives $13M
DURHAM, NC, Precision BioSciences today announced maturity of a $13 million convertible note.- Published at
- by themarketherald.com.au
positivepositiveImugene doses first cancer patient in Oasis trial
Imugene Limited (ASX: IMU), has dosed the first patient in the phase…- Published at
- by themarketherald.com.au
mixedmixed- Published at
- by insidermonkey.com
mixedmixed20 Biggest Health Care Companies in Australia, 2024
In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024.- Published at
- by raskmedia.com.au
mixedmixedS&P/ASX 200 (INDEXASX:XJO) drifts lower into the weekend: Market Matter’s take on Xero Limited (ASX:XRO)
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.55% to 6976.50.- Published at
- by themarketherald.com.au
mixedmixedASX Today: Stocks to watch on Monday
ASX futures were predicting the ASX will open slightly in the green…- Published at
- by globenewswire.com
mixedmixedKineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla
SEATTLE, June 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel...- Published at
- by globenewswire.com
mixedmixedDelveInsight Highlights Major Advances, Transformative Therapies, and 25+ Leading Players Wheeling the Lung Adenocarcinoma Clinical Trial Pipeline Landscape
The prevalence of lung adenocarcinoma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing...- Published at
- by stockhead.com.au
mixedmixedShort & Caught: Flight Centre rises 50% YTD but still hitting turbulence, Zip moving up charts
Flight Centre (ASX:FLT) continues to be targeted by short sellers, while ZIP CO (ASX:ZIP) is now the second most ASX shorted stock.ZIZTFSYA.AXNXT.AXNXDCFNVX.AXNVNXFMYX.AXMAF.AXLKE.AXIEL.AXCXO.AXCXL.AXBGA.AXAVZ.AXPDN.AXMP1.AXMGPPFLTR.AXJBH.AXFLT.AXBOQ.AXBOE.AXARB.AXWEBJFWEB.AXTPW.AXSYR.AXSMUPFSMSMYSHV.AXSGM.AXPBH.AXOBL.AXNCK.AXMTS.AXMSB.AXMESOMEOBFMCSHFMCRZFLLESYLLESFLLC.AXKGN.AXKGGNFJRV.AXIUGNFIMU.AXFFX.AXEML.AXDYLLFDYL.AXDOW.AXCGC.AXBRG.AXBOALYBOALFBLD.AXAWCMYAWCMFAWC.AXAPXYYAPX.AXAPPEFAMGRFAMA.AXABB.AXA2M.AX- Published at
- by globenewswire.com
mixedmixedGlobal Cancer Vaccine Market to Generate USD 13.41 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
Surge in cases of various types of cancers, including breast, lung, and liver, globally drives growth of the cancer vaccine market....- Published at
- by stockhead.com.au
mixedmixedCheck Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales
The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.PSQ.AXPGC.AXOSX.AXOPT.AXOPTNOXOFNOX.AXIUGNFIMU.AXGSS.AXCYP.AXCKDXFBPH.AXATX.AX4DX.AXZNO.AXSCU.AXRSH.AXPXSLYPXS.AXPAB.AXOCC.AXNC6.AXKZA.AXKMLXFIHL.AXIDT.AXFDMDFDVL.AXCMP.AXBITRFBIT.AXARUXFAMT.AXACR.AX1AD.AXZLD.AXVTG.AXVLS.AXUBI.AXTD1.AXSOMNFSOM.AXRNO.AXRHY.AXRHT.AXRGS.AXRAC.AXPYC.AXPNV.AXPCK.AXPBP.AXOVN.AXOSL.AXONE.AXOIL.AXNYR.AXNXSCFNXS.AXMXC.AXMX1.AXMVF.AXMEM.AXMEB.AXMDR.AXMDC.AXMDBIFLBT.AXIVX.AXIPDQFIPD.AXIMRNWIMRNIMM.AXIMC.AXICR.AXHCT.AXGTG.AXGLH.AXEYE.AXDXB.AXCSL.AXCPH.AXCGS.AXCAN.AXCALZFCAJ.AXBXN.AXBWXXFBWX.AXBNOEFBNO.AXAT1.AXARX.AXAMDHFALC.AXADR.AXADO.AX1ST.AX- Published at
- by stockhead.com.au
mixedmixedCheck Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care
The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.PYC.AXPSQ.AXPGC.AXMSB.AXKZA.AXEYE.AXDVL.AXCAN.AXBXN.AXBNOEFBNO.AXADO.AXSOMNFSOM.AXRSH.AXRHT.AXRGS.AXOSX.AXOSL.AXONE.AXOIL.AXNXSCFNXS.AXMEB.AXMDC.AXMDBIFKMLXFIVX.AXIUGNFIMU.AXIDT.AXGLH.AXCYP.AXCMP.AXCAJ.AXAT1.AXADR.AX1ST.AXZNO.AXZLD.AXVTG.AXVLS.AXUBI.AXTD1.AXSCU.AXRNO.AXRHY.AXRAC.AXPXSLYPXS.AXPNV.AXPCK.AXPBP.AXPAB.AXOVN.AXOPT.AXOPTOCC.AXNYR.AXNOXOFNOX.AXNC6.AXMXC.AXMX1.AXMVF.AXMEM.AXMDR.AXLBT.AXIPDQFIPD.AXIMRNWIMRNIMM.AXIMC.AXIHL.AXICR.AXHCT.AXGTG.AXGSS.AXFDMDFDXB.AXCPH.AXCKDXFCGS.AXCALZFBWXXFBWX.AXBPH.AXBITRFBIT.AXATX.AXARX.AXARUXFAMT.AXAMDHFALC.AXACR.AX4DX.AX1AD.AX